Experimental autoimmune encephalomyelitis induced by immunization of non-obese diabetic (NOD) mice with MOG 35–55 peptide has been described as having relapses with worsening disability (Ignatius Arokia Doss et al., 2015). Here, MOG is linked to experimental autoimmune encephalomyelitis.